Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma

Saved in:

Bibliographic Details
Main Author:	Kai Huang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Cancer Communications
Online Access:	https://doi.org/10.1002/cac2.12628
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
by: Xue Wang, et al.
Published: (2025-01-01)

Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
by: I-Tsu Chyuan, et al.
Published: (2018-01-01)

Progress in immunotherapy for brain metastatic melanoma
by: Shicheng Zheng, et al.
Published: (2025-01-01)

Advances in Immunotherapy for Melanoma: A Comprehensive Review
by: Carmen Rodríguez-Cerdeira, et al.
Published: (2017-01-01)

Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management
by: Anna J. Lomax, et al.
Published: (2018-01-01)

Parasite-Specific IL-17-Type Cytokine Responses and Soluble IL-17 Receptor Levels in Alveolar Echinococcosis Patients
by: Christian J. Lechner, et al.
Published: (2012-01-01)

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
by: Massimo Ralli, et al.
Published: (2020-01-01)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012-01-01)

Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options
by: Marlena Janiczek, et al.
Published: (2020-01-01)

IL-17A and Th17 Cells in Lung Inflammation: An Update on the Role of Th17 Cell Differentiation and IL-17R Signaling in Host Defense against Infection
by: Hsing-Chuan Tsai, et al.
Published: (2013-01-01)

Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles
by: Kowichi Jimbow, et al.
Published: (2013-01-01)

Potential Involvement of IL-17F in Asthma
by: Kyoko Ota, et al.
Published: (2014-01-01)

Evolutionary Insights into IL17A in Lagomorphs
by: Fabiana Neves, et al.
Published: (2015-01-01)

Differences in expression profiles in malingant melanoma patients according to immunotherapy response
by: E. N. Lukyanova, et al.
Published: (2018-01-01)

Immunotherapy for Metastatic Melanoma with Right Atrial Involvement in a Patient with Rheumatoid Arthritis
by: Zachary Benson, et al.
Published: (2017-01-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Salivary IL-17A, IL-17F, and TNF-α Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer
by: Kinga Zielińska, et al.
Published: (2020-01-01)

Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
by: Shangjun Sun, et al.
Published: (2018-01-01)

Dual Roles of IL-27 in Cancer Biology and Immunotherapy
by: Marina Fabbi, et al.
Published: (2017-01-01)

Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
by: Mengzhu Sun, et al.
Published: (2025-01-01)

Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma
by: Brenen P. Swofford, et al.
Published: (2017-01-01)

Blockade of IL-17A/IL-17R Pathway Protected Mice from Sepsis-Associated Encephalopathy by Inhibition of Microglia Activation
by: Bo Ye, et al.
Published: (2019-01-01)

IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients
by: Priscilla Stela Santana de Oliveira, et al.
Published: (2015-01-01)

TLR2 Elicits IL-17-Mediated RANKL Expression, IL-17, and OPG Production in Neutrophils from Arthritic Mice
by: Viktoriya Milanova, et al.
Published: (2014-01-01)

Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis
by: Ma Liang, et al.
Published: (2018-01-01)

Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
by: Tetsuya Tomita, et al.
Published: (2023-02-01)

Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy
by: Fermín E. González, et al.
Published: (2018-01-01)

Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
by: Zahid Rafiq, et al.
Published: (2025-01-01)

Lack of Association of the Polymorphisms IL-17A (−197G/A) and IL-17F (+7488A/G) with Multibacillary Leprosy in Mexican Patients
by: Mónica Escamilla-Tilch, et al.
Published: (2014-01-01)

Targeting Innate Immune Cells for Immunotherapy
by: Leandro J. Carreño, et al.
Published: (2017-01-01)

Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
by: Merve Kulbay, et al.
Published: (2025-01-01)

IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
by: Shujuan Li, et al.
Published: (2012-01-01)

IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid
by: Agnieszka Zebrowska, et al.
Published: (2013-01-01)

IL-33 Deficiency Attenuates Lung Inflammation by Inducing Th17 Response and Impacting the Th17/Treg Balance in LPS-Induced ARDS Mice via Dendritic Cells
by: Li Cheng, et al.
Published: (2022-01-01)

The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients
by: Joana Maira Valentini Zacarias, et al.
Published: (2015-01-01)

Notch-Hes1 Signaling Regulates IL-17A+γδ+T Cell Expression and IL-17A Secretion of Mouse Psoriasis-Like Skin Inflammation
by: Yanqin Wang, et al.
Published: (2020-01-01)

The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
by: Xiang-Tian Meng, et al.
Published: (2020-01-01)

Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
by: Haitham M. Saad, et al.
Published: (2024-12-01)

Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
by: Florence Vallelian, et al.
Published: (2023-01-01)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
by: Lu Zhang, et al.
Published: (2012-01-01)